naltrexone and disulfiram

naltrexone has been researched along with disulfiram in 146 studies

Research

Studies (146)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	18 (12.33)	18.2507
2000's	63 (43.15)	29.6817
2010's	50 (34.25)	24.3611
2020's	15 (10.27)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Kosten, TA; Kosten, TR	1
Eames, B	1
Brewer, C	1
Wodak, A	1
Schuckit, MA	1
Kranzler, HR; Meza, E	1
Swift, RM	1
Miller, NS; Smith, DE	1
Finlayson, RE; Morse, RM; Tinsley, JA	1
Sinclair, JD	1
Duncan, D; Femino, J; Nirenberg, T; Swift, RM	1
Gache, P; Siegrist, G	1
Carey, TS; Crews, FT; Garbutt, JC; Lohr, KN; West, SL	1
Malerich, JA	1
Rueff, B	1
Mason, B	1
Carey, TS; Crews, FT; Garbutt, JC; Jackman, AM; Lohr, KN; Lux, LJ; Tolleson-Rinehart, S; West, SL	1
Gordon, SM	1
Anton, RF	1
Cornelius, JD; Salloum, IM; Thase, ME	1
Yarborough, WH	1
Fideli, LP; Lejoyeux, M	1
Graham, R; Whelan, G; Wodak, AD	1
Mason, BJ	1
Bransberger, P; Crosse, S; Kranzler, HR; Mark, TL; Poole, VH; Song, X	1
Brewer, C; Streel, E	1
Pienaar, W	1
Fiore, LD; Gagnon, DR; Hermos, JA; Young, MM	1
Bailey, KP	1
Lee, TH	1
Kosten, TR; Sofuoglu, M	1
Kenna, GA; McGeary, JE; Swift, RM	2
Solhkhah, R; Wilens, TE	1
Baltieri, DA; Castro, LA	1
Carroll, K; Levinson, C; Nich, C; Petrakis, IL; Poling, J; Rounsaville, B	1
O'Brien, CP	1
Berglund, M; Johnson, BA; Lesch, OM; Litten, RZ; Mann, K; Swift, RM; Willenbring, ML	1
Buonopane, A; Petrakis, IL	1
Williams, SH	1
Egli, M; Heilig, M	1
Jung, YC; Namkoong, K	1
Leeman, RF; Starosta, AN; Volpicelli, JR	1
Balester-Mouret, S; Batel, P	1
Green, AI	1
Ducharme, LJ; Knudsen, HK; Roman, PM	2
Kranzler, HR	2
Carroll, K; Levinson, C; Nich, C; Petrakis, IL; Poling, J; Ralevski, E; Rounsaville, B	1
Bleich, S; Hillemacher, T; Kornhuber, J	1
Roesner, S; Soyka, M	1
Diehl, A; Mann, K	1
Lucchini, A; Manzato, E; Nava, F; Premi, S	1
Mørland, J	1
Antonilli, L; Cioce, AM; Giudici, FD; Grassi, MC; Nencini, P	1
Quertemont, E; Tambour, S	1
Swift, R	1
Peterson, AM	1
McDonough, KP	1
Brunette, MF; Drake, RE; Green, AI; Noordsy, DL	1
Carroll, K; Levinson, C; Nich, C; Petrakis, I; Poling, J; Ralevski, E; Rounsaville, B	1
Garnick, DW; Hodgkin, D; Horgan, CM; Merrick, EL; Reif, S	1
Brunette, MF; Green, AI; Noordsy, DL; O'Keefe, C	1
D'Amelio, R; Falkai, P; Wobrock, T	1
Johnson, BA	1
Kuehn, BM	1
Dackis, C; Kampman, KM; Lynch, KG; O'Brien, CP; Pettinati, HM; Rabinowitz, AR; Xie, H	1
Berglund, M; Gorelick, D; Hesselbrock, V; Johnson, BA; Kranzler, HR; Möller, HJ; Soyka, M	1
Blanc, F; Perney, P; Rigole, H	1
Kassed, CA; Kranzler, HR; Levit, KR; Mark, TL; Vandivort-Warren, R	1
Garbutt, JC	1
Diehl, A; Herre, H; Kiefer, F; Mann, K; Mutschler, J; Vollmert, C	1
Alho, H; Hyytiä, P	1
de Silva, V; Hanwella, R	1
Amato, L; Davoli, M; Pani, PP; Trogu, E; Vacca, R; Vecchi, S	1
Olive, MF	1
Bowe, T; Harris, AH; Humphreys, KN; Kivlahan, DR	1
Chalk, M; Gastfriend, DR; Kranzler, HR; Mark, TL; Montejano, LB	1
Abraham, AJ; Knudsen, HK; Roman, PM	2
Calvo Vecino, JM; del Blanco Narciso, BB; Orts Castro, A	1
Baser, O; Chalk, M; Gastfriend, DR; Rawson, R	1
Krogh, J; Nordentoft, M; Petrov, I	1
Bujarski, S; Courtney, KE; Ray, LA; Squeglia, LM	1
Spanagel, R; Vengeliene, V	1
Book, SW; Miller, PM; Stewart, SH	1
Clark, DB	1
Bowe, T; Ellerbe, L; Gordon, AJ; Hagedorn, H; Harris, AHS; Kivlahan, D; Lembke, A; Oliva, E; Reeder, RN; Trafton, JA	1
O'Connor, PG; O'Malley, SS	1
Krishnan-Sarin, S; Krystal, JH; O'Malley, S	1
Douaihy, AB; Kelly, TM; Sullivan, C	1
Franck, J; Jayaram-Lindström, N	1
Cummings, GR; Heinrich, CJ	1
Gianoli, MO; McCarthy, E; Petrakis, I; Ralevski, E	1
Liang, J; Olsen, RW	1
Friedmann, PD; Park, TW	1
Borro, P; Leone, S; Testino, G	1
Agabio, R; Franconi, F; Gessa, GL; Pani, PP; Preti, A	1
Gofman, AG; Ponizovskiy, PA	1
Helton, SG; Lohoff, FW	1
Cicin-Šain, L; Kovak-Mufić, A; Marušić, S; Matošić, A; Vidrih, B	1
Salisbury-Afshar, E	1
Bramness, JG; Mann, K; Wurst, FM	1
Bowe, T; Christopher, M; Finlay, AK; Gidwani, R; Hagedorn, H; Harris, AH; Kay, C; Nevedal, A; Rosen, C	1
Brewer, C; Skinner, M; Streel, E	1
Goh, ET; Morgan, MY	1
Manolopoulos, VG; Ragia, G	1
Lyon, J	1
Bonnet, U; Dembski, N; Niederhofer, A; Niederhofer, E; Nyhuis, PW; Scherbaum, N; Schifano, F; Specka, M; Tenbergen, M	1
Falk, DE; Fertig, J; Leggio, L; Litten, RZ; Ryan, ML	2
Kranzler, HR; Soyka, M	1
Bramness, JG; Heldal, AT; Lobmaier, PPK; Skurtveit, S; Vederhus, JK	1
Harris, AHS; Matson, TE; Williams, EC	1
Warren, D	1
Alho, H; Castrén, S; Mäkelä, N	1
Buchholz, J; Saxon, AJ	1
Beaglehole, B; Boden, JM; Foulds, J; Mulder, RT	1
Hartwell, KJ; Korte, JE; McRae-Clark, AL; Walker, JR	1
de Jong, J; Neven, A; Pieterse, BH	1
Adhikari, S; Chapagai, M; Dhungana, S; Ojha, SP; Pant, SB; Tulachan, P	1
Fairbanks, J; Karpyak, VM; Kolla, BP; Loukianova, LL; Schneekloth, TD; Sinha, S; Umbreit, A	1
Lohoff, FW	1
Balasanova, AA; Patel, AK	1
Greenland, M; Kelty, E; Preen, D; Terplan, M	1
Brasch, J; Chaimowitz, G; MacKillop, J; Minhas, M; Olagunju, AT; Slavin-Stewart, C; Turna, J	1
Worley, J	1
Burnette, EM; Gillis, AJ; Grodin, EN; Hurley, B; Meredith, LR; Miotto, K; Nieto, SJ; Ray, LA	1
Addolorato, G; Antonelli, M; Sestito, L; Tarli, C	1
Bain, PA; Busch, AB; Huskamp, HA; Hyland, CJ; McDowell, MJ	1
Alto, M; Giusto, A; Greene, MC; Johnson, RM; Kane, J; Lovero, K; McClendon, J; Nicholson, T; Stockton, M; Tol, WA; Wainberg, ML	1
Conigrave, JH; Conigrave, KM; Lee, KSK; Purcell-Khodr, G; Vnuk, J	1
Drexler, K; Hsu, M; Malhotra, A; Tang, YL	1

Reviews

78 review(s) available for naltrexone and disulfiram

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Pharmacological blocking agents for treating substance abuse. The Journal of nervous and mental disease, 1991, Volume: 179, Issue:10 Topics: Alcoholism; Animals; Behavior Therapy; Disulfiram; Drug Antagonism; Drug Design; Humans; Naltrexone; Narcotic Antagonists; Neurosciences; Opioid-Related Disorders; Rats; Substance-Related Disorders	1991
Managing illicit drug use. A practical guide. Drugs, 1994, Volume: 47, Issue:3 Topics: Buprenorphine; Counseling; Disulfiram; Humans; Methadone; Methadyl Acetate; Naltrexone; Psychotherapy; Self-Help Groups; Substance Abuse Treatment Centers; Substance-Related Disorders	1994
Recent developments in the pharmacotherapy of alcohol dependence. Journal of consulting and clinical psychology, 1996, Volume: 64, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Anti-Anxiety Agents; Buspirone; Disulfiram; Ethanol; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Substance-Related Disorders; Taurine	1996
Closing the gap between alcoholism research and practice: the case for pharmacotherapy. Psychiatric services (Washington, D.C.), 1996, Volume: 47, Issue:9 Topics: Alcoholism; Antidepressive Agents, Tricyclic; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy; Research; Serotonin Agents	1996
The pharmacological treatment of alcohol dependence. Medicine and health, Rhode Island, 1997, Volume: 80, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Comorbidity; Depression; Disulfiram; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Taurine	1997
The integration of pharmacotherapy and nonpharmacotherapy. Journal of addictive diseases, 1997, Volume: 16, Issue:4 Topics: Alcohol Deterrents; Behavior, Addictive; Combined Modality Therapy; Disease Susceptibility; Disulfiram; Drug Interactions; Humans; Naltrexone; Narcotic Antagonists; Patient Acceptance of Health Care; Psychotherapy; Psychotropic Drugs; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome	1997
Developments in the treatment of alcoholism. Mayo Clinic proceedings, 1998, Volume: 73, Issue:9 Topics: Alcohol Deterrents; Alcoholism; Anti-Anxiety Agents; Benzodiazepines; Continuity of Patient Care; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy	1998
Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA, 1999, Apr-14, Volume: 281, Issue:14 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Lithium; Naltrexone; Narcotic Antagonists; Serotonin Agents; Taurine	1999
[Evaluation of drug treatment of primary alcoholism]. La Revue du praticien, 1999, Feb-15, Volume: 49, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Follow-Up Studies; Humans; Naltrexone; Self-Help Groups; Taurine; Treatment Outcome	1999
Pharmacotherapy for alcohol dependence. Evidence report/technology assessment (Summary), 1999, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Health Policy; Humans; Lithium; Naltrexone; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Serotonin Agents; Taurine; United States	1999
Pharmacologic approaches to the management of alcoholism. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 20 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Behavior, Addictive; Clinical Trials as Topic; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome	2001
Comorbid alcoholism and depression: treatment issues. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 20 Topics: Alcohol Deterrents; Alcoholism; Antidepressive Agents; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Counseling; Depressive Disorder; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2001
[Long-term treatment of alcohol dependance]. Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:5 Suppl Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Combined Modality Therapy; Disulfiram; Family Therapy; Humans; Long-Term Care; Naltrexone; Psychotherapy; Self-Help Groups; Social Support; Social Work; Taurine; Treatment Outcome	2002
New pharmacotherapies for alcohol dependence. The Medical journal of Australia, 2002, Jul-15, Volume: 177, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Australia; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Self-Help Groups; Taurine; Treatment Outcome	2002
Acamprosate. Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism, 2003, Volume: 16 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Double-Blind Method; Humans; Multicenter Studies as Topic; Naltrexone; Randomized Controlled Trials as Topic; Taurine; Treatment Outcome	2003
Learning the language of abstinence in addiction treatment: some similarities between relapse-prevention with disulfiram, naltrexone, and other pharmacological antagonists and intensive "immersion" methods of foreign language teaching. Substance abuse, 2003, Volume: 24, Issue:3 Topics: Adaptation, Psychological; Alcohol Deterrents; Alcoholism; Behavior Control; Disulfiram; Humans; Language; Naltrexone; Narcotic Antagonists; Secondary Prevention; Substance-Related Disorders; Teaching	2003
Pharmacological treatments for substance use disorders. Journal of psychosocial nursing and mental health services, 2004, Volume: 42, Issue:8 Topics: Adrenergic beta-Antagonists; Alcohol Deterrents; Anti-Anxiety Agents; Benzodiazepines; Buprenorphine; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neurobiology; Neuropharmacology; Psychopharmacology; Substance Withdrawal Syndrome; Substance-Related Disorders	2004
Pharmacologic management of relapse prevention in addictive disorders. The Psychiatric clinics of North America, 2004, Volume: 27, Issue:4 Topics: Administration, Cutaneous; Administration, Oral; Alcohol Deterrents; Alcoholism; Behavior, Addictive; Disulfiram; Humans; Naltrexone; Narcotics; Nicotine; Smoking Cessation; Smoking Prevention; Substance-Related Disorders	2004
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Nov-01, Volume: 61, Issue:21 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Animals; Clinical Trials as Topic; Disulfiram; Excitatory Amino Acid Antagonists; Humans; Naltrexone; Narcotic Antagonists; Taurine	2004
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2004, Nov-15, Volume: 61, Issue:22 Topics: Alcohol Deterrents; Alcoholism; Aripiprazole; Behavior Therapy; Disulfiram; Fructose; Humans; Naltrexone; Ondansetron; Pharmacogenetics; Piperazines; Quinolones; Topiramate	2004
Pharmacotherapy of adolescent alcohol and other drug use disorders. Alcohol health and research world, 1998, Volume: 22, Issue:2 Topics: Adolescent; Adolescent Behavior; Alcohol-Induced Disorders; Disulfiram; Humans; Naltrexone; Substance-Related Disorders	1998
Anticraving medications for relapse prevention: a possible new class of psychoactive medications. The American journal of psychiatry, 2005, Volume: 162, Issue:8 Topics: Alcoholism; Behavior, Addictive; Bupropion; Cocaine-Related Disorders; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Psychotropic Drugs; Secondary Prevention; Substance-Related Disorders; Tobacco Use Disorder	2005
Pharmacotherapy of alcohol use disorders. Substance use & misuse, 2005, Volume: 40, Issue:13-14 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Amitriptyline; Antidepressive Agents, Tricyclic; Comorbidity; Disulfiram; Dopamine; Drug Interactions; Ethanol; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Mental Disorders; Naltrexone; Narcotics; Serotonin; Taurine	2005
Medications for treating alcohol dependence. American family physician, 2005, Nov-01, Volume: 72, Issue:9 Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Disulfiram; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naltrexone; Patient Compliance; Randomized Controlled Trials as Topic; Serotonin Agents; Taurine; Treatment Outcome	2005
Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacology & therapeutics, 2006, Volume: 111, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Baclofen; Corticotropin-Releasing Hormone; Disease Models, Animal; Disulfiram; Fructose; Humans; Naltrexone; Neuropeptide Y; Nociceptin; Ondansetron; Opioid Peptides; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Taurine; Topiramate	2006
Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention. Yonsei medical journal, 2006, Apr-30, Volume: 47, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; gamma-Aminobutyric Acid; Glutamine; Humans; Models, Biological; Models, Neurological; N-Methylaspartate; Naltrexone; Narcotic Antagonists; Neurons; Polymorphism, Genetic; Receptors, Opioid, mu; Recurrence; Taurine	2006
Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches. The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 7 Topics: Alcohol Deterrents; Alcoholism; Antipsychotic Agents; Clozapine; Comorbidity; Diagnosis, Dual (Psychiatry); Disulfiram; Drug Therapy, Combination; Humans; Naltrexone; Narcotic Antagonists; Schizophrenia; Substance-Related Disorders; Treatment Outcome	2006
[Neurobiological mechanisms and pharmacological treatment options for alcohol craving]. Fortschritte der Neurologie-Psychiatrie, 2007, Volume: 75, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Neurosecretory Systems; Neurotransmitter Agents; Receptors, Glutamate; Taurine	2007
New pharmacological approaches for the treatment of alcoholism. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:17 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Carbamazepine; Depression; Disease Models, Animal; Disulfiram; Fructose; Humans; Naltrexone; Secondary Prevention; Taurine; Topiramate	2006
Trends in the adoption of medications for alcohol dependence. Journal of clinical psychopharmacology, 2006, Volume: 26 Suppl 1 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Longitudinal Studies; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Taurine; United States	2006
[Pharmacological relapse prevention in alcohol and tobacco dependence]. Der Internist, 2007, Volume: 48, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Taurine; Tobacco Use Disorder	2007
Preclinical and clinical pharmacology of alcohol dependence. Fundamental & clinical pharmacology, 2007, Volume: 21, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Disulfiram; Dopamine; GABA Modulators; Glutamic Acid; Humans; Naltrexone; Narcotic Antagonists; Serotonin; Taurine	2007
Emerging approaches to managing alcohol dependence. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Mar-01, Volume: 64, Issue:5 Suppl 3 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Behavior Therapy; Brain; Disulfiram; Drug Therapy, Combination; Ethanol; Humans; Naltrexone; Taurine	2007
Improving adherence in patients with alcohol dependence: a new role for pharmacists. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Mar-01, Volume: 64, Issue:5 Suppl 3 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Behavior Therapy; Disulfiram; Humans; Naltrexone; Patient Compliance; Pharmacists; Professional Role; Taurine; Treatment Refusal	2007
Substance abuse and schizophrenia: pharmacotherapeutic intervention. Journal of substance abuse treatment, 2008, Volume: 34, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Antipsychotic Agents; Clozapine; Disulfiram; Drug Interactions; Humans; Naltrexone; Narcotics; Schizophrenia; Substance-Related Disorders; Taurine	2008
[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review]. Der Nervenarzt, 2008, Volume: 79, Issue:1 Topics: Alcohol Deterrents; Alcoholism; Algorithms; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clinical Trials as Topic; Comorbidity; Diagnosis, Dual (Psychiatry); Disulfiram; Dose-Response Relationship, Drug; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Naltrexone; Narcotic Antagonists; Schizophrenia; Substance-Related Disorders	2008
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochemical pharmacology, 2008, Jan-01, Volume: 75, Issue:1 Topics: Acamprosate; Alcoholism; Animals; Baclofen; Disulfiram; Fructose; Humans; Naltrexone; Ondansetron; Receptors, N-Methyl-D-Aspartate; Ritanserin; Selective Serotonin Reuptake Inhibitors; Taurine; Topiramate	2008
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2008, Volume: 9, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Biological Psychiatry; Carbamazepine; Disulfiram; Fructose; Health Planning Guidelines; Humans; Naltrexone; Ondansetron; Societies, Scientific; Substance-Related Disorders; Taurine; Topiramate	2008
[Alcohol dependence: diagnosis and treatment]. La Revue de medecine interne, 2008, Volume: 29, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Cognitive Behavioral Therapy; Disulfiram; Humans; Motivation; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Taurine	2008
The state of pharmacotherapy for the treatment of alcohol dependence. Journal of substance abuse treatment, 2009, Volume: 36, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Baclofen; Delayed-Action Preparations; Disulfiram; Fructose; Humans; Medication Adherence; Naltrexone; Taurine; Temperance; Topiramate	2009
[Recent results in relaps prevention of alcoholism with Disulfiram]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2008, Volume: 22, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Aldehyde Dehydrogenase; Combined Modality Therapy; Disulfiram; Drug Interactions; Drug Therapy, Combination; Germany; Humans; Metabolic Clearance Rate; Motivation; Naltrexone; Randomized Controlled Trials as Topic; Secondary Prevention; Taurine	2008
Disulfiram for the treatment of cocaine dependence. The Cochrane database of systematic reviews, 2010, Jan-20, Issue:1 Topics: Cocaine-Related Disorders; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic	2010
[Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review]. Ugeskrift for laeger, 2011, Nov-28, Volume: 173, Issue:48 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Evidence-Based Medicine; Humans; Naltrexone; Taurine; Treatment Outcome	2011
New pharmacological treatment strategies for relapse prevention. Current topics in behavioral neurosciences, 2013, Volume: 13 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Animals; Disulfiram; Drugs, Investigational; History, 18th Century; History, 21st Century; Humans; Naltrexone; Receptors, N-Methyl-D-Aspartate; Secondary Prevention; Taurine	2013
Medical treatment of alcohol dependence: a systematic review. International journal of psychiatry in medicine, 2011, Volume: 42, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Fructose; Humans; Naltrexone; Narcotic Antagonists; Off-Label Use; Taurine; Topiramate; Treatment Outcome	2011
Medications for unhealthy alcohol use: across the spectrum. Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism, 2011, Volume: 33, Issue:4 Topics: Acamprosate; Alcohol Drinking; Alcoholism; Animals; Disulfiram; Dopamine Agents; Fructose; Humans; Naltrexone; Selective Serotonin Reuptake Inhibitors; Taurine; Topiramate	2011
Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism. Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism, 2008, Volume: 31, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Brain Chemistry; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome	2008
Medications for substance use disorders. Social work in public health, 2013, Volume: 28, Issue:3-4 Topics: Alcohol Deterrents; Alcoholism; Analgesics, Opioid; Behavior Therapy; Behavior, Addictive; Buprenorphine; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Disorder	2013
Pharmacotherapy for alcohol dependence: status of current treatments. Current opinion in neurobiology, 2013, Volume: 23, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Disulfiram; Humans; Multicenter Studies as Topic; Naltrexone; Narcotic Antagonists; Taurine	2013
Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors. Acta pharmacologica Sinica, 2014, Volume: 35, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Benzodiazepines; Disulfiram; Ethanol; Fructose; Humans; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Plant Preparations; Receptors, GABA-A; Taurine; Topiramate	2014
Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders. Rhode Island medical journal (2013), 2014, Oct-01, Volume: 97, Issue:10 Topics: Acamprosate; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Directive Counseling; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Practice Patterns, Physicians'; Substance-Related Disorders; Taurine; United States	2014
Treatment of alcohol dependence: recent progress and reduction of consumption. Minerva medica, 2014, Volume: 105, Issue:6 Topics: Acamprosate; Age of Onset; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Binge Drinking; Contraindications; Craving; Disulfiram; Drugs, Investigational; Europe; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Naltrexone; Neurotransmitter Agents; Randomized Controlled Trials as Topic; Sodium Oxybate; Taurine	2014
Efficacy of Medications Approved for the Treatment of Alcohol Dependence and Alcohol Withdrawal Syndrome in Female Patients: A Descriptive Review. European addiction research, 2016, Volume: 22, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol Withdrawal Delirium; Alcoholism; Anticonvulsants; Benzodiazepines; Disulfiram; Female; Humans; Male; Naltrexone; Sex Factors; Taurine; Treatment Outcome	2016
[Depression in alcohol addicted patients]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:7 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Comorbidity; Depressive Disorder; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Taurine	2015
Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders. Psychiatry research, 2015, Dec-15, Volume: 230, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Anxiety Disorders; Comorbidity; Depressive Disorder, Major; Disulfiram; Fructose; Humans; Naltrexone; Pharmacogenetics; Precision Medicine; Taurine; Topiramate; United States	2015
NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION. Acta clinica Croatica, 2016, Volume: 55, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Brain; Disulfiram; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Minisatellite Repeats; Monoamine Oxidase; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Norepinephrine; Ondansetron; Polymorphism, Genetic; Serotonin; Synaptic Transmission; Taurine	2016
Supervised Disulfiram's Superior Effectiveness in Alcoholism Treatment: Ethical, Methodological, and Psychological Aspects. Alcohol and alcoholism (Oxford, Oxfordshire), 2017, Mar-09, Volume: 52, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Bioethical Issues; Disulfiram; Humans; Naltrexone; Taurine	2017
Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore. Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:7 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Baclofen; Disulfiram; Drug Combinations; Fructose; Humans; Naltrexone; Polymorphism, Single Nucleotide; Pyridoxine; Pyrrolidonecarboxylic Acid; Taurine; Topiramate; Treatment Outcome	2017
Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond. Current pharmaceutical biotechnology, 2017, Volume: 18, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Pharmacogenetics; Polymorphism, Genetic; Precision Medicine; Taurine	2017
Advances in Pharmacotherapy Development: Human Clinical Studies. Handbook of experimental pharmacology, 2018, Volume: 248 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone	2018
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. JAMA, 2018, 08-28, Volume: 320, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Counseling; Disulfiram; Humans; Naltrexone; Taurine	2018
Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions. Addiction science & clinical practice, 2019, 02-12, Volume: 14, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Clinical Trials as Topic; Disulfiram; Naltrexone; Practice Patterns, Physicians'; Topiramate; United States; United States Department of Veterans Affairs; Veterans	2019
Selecting an appropriate alcohol pharmacotherapy: review of recent findings. Current opinion in psychiatry, 2019, Volume: 32, Issue:4 Topics: Acamprosate; Alcoholism; Antidepressive Agents; Baclofen; Cholinergic Agonists; Disulfiram; Gabapentin; Humans; Naltrexone; Ondansetron; Randomized Controlled Trials as Topic; Treatment Outcome	2019
Medications to treat cocaine use disorders: current options. Current opinion in psychiatry, 2019, Volume: 32, Issue:4 Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Central Nervous System Stimulants; Cocaine-Related Disorders; Disulfiram; Humans; Naltrexone	2019
Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies. Handbook of experimental pharmacology, 2020, Volume: 258 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Drug Development; Humans; Naltrexone	2020
[The pharmacological treatment of PTSD and alcohol use disorder: a systematic literature review]. Tijdschrift voor psychiatrie, 2019, Volume: 61, Issue:10 Topics: Alcohol-Related Disorders; Disulfiram; Drug Therapy, Combination; Humans; Naltrexone; Randomized Controlled Trials as Topic; Sertraline; Stress Disorders, Post-Traumatic	2019
Evidence-Based Pharmacotherapies for Alcohol Use Disorder: Clinical Pearls. Mayo Clinic proceedings, 2020, Volume: 95, Issue:9 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Anticonvulsants; Disulfiram; Evidence-Based Medicine; Humans; Mass Screening; Naltrexone; Off-Label Use; Practice Guidelines as Topic	2020
Pharmacotherapies and personalized medicine for alcohol use disorder: a review. Pharmacogenomics, 2020, Volume: 21, Issue:15 Topics: Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Pharmacogenetics; Pharmacogenomic Testing; Precision Medicine	2020
Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider? Drugs, 2021, Volume: 81, Issue:7 Topics: Acamprosate; Alcohol Abstinence; Alcohol Deterrents; Alcoholism; Animals; Comorbidity; Disulfiram; Female; Fetal Alcohol Spectrum Disorders; Humans; Naltrexone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Substance Withdrawal Syndrome	2021
Pharmacological interventions for alcohol misuse in correctional settings: A systematic review. Alcoholism, clinical and experimental research, 2022, Volume: 46, Issue:1 Topics: Alcohol Deterrents; Alcoholism; Correctional Facilities; Criminal Behavior; Disulfiram; Humans; Naltrexone; Recidivism; Treatment Outcome	2022
Review of Evidence-Based Strategies to Treat Alcohol Use Disorder. Journal of psychosocial nursing and mental health services, 2021, Volume: 59, Issue:12 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone	2021
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. Drugs, 2022, Volume: 82, Issue:3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Baclofen; Disulfiram; Humans; Naltrexone; Topiramate	2022
Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective? European journal of internal medicine, 2022, Volume: 103 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Disulfiram; Humans; Naltrexone	2022
Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review. Journal of substance abuse treatment, 2023, Volume: 144 Topics: Acamprosate; Adolescent; Alcohol Drinking; Alcoholism; Disulfiram; Humans; Naltrexone; Primary Health Care; Randomized Controlled Trials as Topic; United States	2023
Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries. The Cochrane database of systematic reviews, 2023, 05-09, Volume: 5 Topics: Acamprosate; Alcoholism; Amitriptyline; Developing Countries; Disulfiram; Humans; Male; Mirtazapine; Naltrexone; Ondansetron; Topiramate	2023
Overview of Alcohol Use Disorder. The American journal of psychiatry, 2023, 08-01, Volume: 180, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Child; Disulfiram; Ethanol; Humans; Naltrexone; United States	2023
Medication treatment for alcohol use disorder in special populations. The American journal on addictions, 2023, Volume: 32, Issue:5 Topics: Acamprosate; Adolescent; Alcoholism; Analgesics, Opioid; Disulfiram; Humans; Naltrexone; Narcotic Antagonists	2023

Trials

10 trial(s) available for naltrexone and disulfiram

Article	Year
Patterns of dispensed disulfiram and naltrexone for alcoholism treatment in a veteran patient population. Alcoholism, clinical and experimental research, 2004, Volume: 28, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Alcoholism; Confidence Intervals; Disulfiram; Drug Prescriptions; Humans; Middle Aged; Multivariate Analysis; Naltrexone; New England; Survival Analysis; Veterans	2004
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biological psychiatry, 2005, May-15, Volume: 57, Issue:10 Topics: Alcohol Deterrents; Alcoholism; Diagnosis, Dual (Psychiatry); Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Treatment Outcome	2005
Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biological psychiatry, 2006, Oct-01, Volume: 60, Issue:7 Topics: Adult; Alcohol Deterrents; Alcoholism; Analysis of Variance; Diagnosis, Dual (Psychiatry); Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Stress Disorders, Post-Traumatic; Temperance; Treatment Outcome	2006
Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst. Journal of psychoactive drugs, 2006, Volume: 38, Issue:3 Topics: Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Biomarkers; Disulfiram; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Sodium Oxybate; Temperance	2006
Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: a pilot study. Pharmacological research, 2007, Volume: 55, Issue:2 Topics: Adult; Cocaine; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Patient Compliance; Pilot Projects; Time Factors; Treatment Outcome	2007
Naltrexone and disulfiram in patients with alcohol dependence and current depression. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Alcohol Deterrents; Alcoholism; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Connecticut; Depressive Disorder, Major; Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Gastrointestinal Diseases; Humans; Male; Massachusetts; Middle Aged; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans	2007
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addictive behaviors, 2008, Volume: 33, Issue:5 Topics: Adolescent; Adult; Aged; Alcohol Deterrents; Alcoholism; Cocaine-Related Disorders; Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Treatment Outcome	2008
Quality of life in veterans with alcohol dependence and co-occurring mental illness. Addictive behaviors, 2014, Volume: 39, Issue:2 Topics: Alcohol Abstinence; Alcohol Deterrents; Alcoholism; Analysis of Variance; Brief Psychiatric Rating Scale; Comorbidity; Connecticut; Diagnosis, Dual (Psychiatry); Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Interviews as Topic; Male; Massachusetts; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Psychotropic Drugs; Quality of Life; Severity of Illness Index; Treatment Outcome; Veterans	2014
Effectiveness of Psychoanalytic-Interactional Group Therapy vs. Behavioral Group Therapy in Routine Outpatient Treatment of Alcohol-Dependent Patients. Substance use & misuse, 2018, 02-23, Volume: 53, Issue:3 Topics: Acamprosate; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Disulfiram; Female; Humans; Male; Middle Aged; Naltrexone; Outpatients; Psychoanalytic Therapy; Psychotherapy, Group; Recurrence; Secondary Prevention; Taurine; Treatment Outcome	2018
Low rates of prescribing alcohol relapse prevention medicines in Australian Aboriginal Community Controlled Health Services. Drug and alcohol review, 2023, Volume: 42, Issue:7 Topics: Acamprosate; Adult; Alcoholism; Australia; Australian Aboriginal and Torres Strait Islander Peoples; Chronic Disease; Disulfiram; Health Services, Indigenous; Humans; Male; Middle Aged; Naltrexone; Secondary Prevention	2023

Other Studies

58 other study(ies) available for naltrexone and disulfiram

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Staying off the merry go round: prescribing habits for recovering patients. Journal of the South Carolina Medical Association (1975), 1990, Volume: 86, Issue:1 Topics: Analgesics; Comorbidity; Disulfiram; Drug Prescriptions; Humans; Hypnotics and Sedatives; Mental Disorders; Naltrexone; Substance-Related Disorders; Tranquilizing Agents	1990
Naltrexone in alcohol dependence. Lancet (London, England), 1995, Nov-18, Volume: 346, Issue:8986 Topics: Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Patient Compliance	1995
New treatment options for substance abuse from a public health viewpoint. Annals of medicine, 1998, Volume: 30, Issue:4 Topics: Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Disulfiram; Extinction, Psychological; Humans; Naltrexone; Narcotic Antagonists	1998
Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism. Journal of addictive diseases, 1998, Volume: 17, Issue:3 Topics: Adult; Aged; Alcohol Deterrents; Alcoholism; Combined Modality Therapy; Disulfiram; Female; Humans; Male; Middle Aged; Naltrexone; Patient Acceptance of Health Care	1998
[Medical treatment of alcohol dependence]. Revue medicale de la Suisse romande, 1998, Volume: 118, Issue:9 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine	1998
Prevention of relapse in alcohol dependence. American family physician, 1999, Apr-01, Volume: 59, Issue:7 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Behavior Therapy; Disulfiram; Family; Humans; Naltrexone; Narcotic Antagonists; Recurrence; Self-Help Groups; Taurine	1999
Medical allies against alcoholism. Health news (Waltham, Mass.), 1999, Jun-25, Volume: 5, Issue:8 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Taurine	1999
Does the alcoholic's remedy come in a pill? Behavioral healthcare tomorrow, 2001, Volume: 10, Issue:4 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Excitatory Amino Acid Antagonists; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Ondansetron; Patient Compliance; Serotonin Antagonists; Social Support; Taurine; United States	2001
Addiction medicine for the primary care physician. The Journal of the Oklahoma State Medical Association, 2001, Volume: 94, Issue:11 Topics: Acamprosate; Alcohol Deterrents; Alcoholics Anonymous; Alcoholism; Antidepressive Agents, Tricyclic; Disulfiram; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Primary Health Care; Recurrence; Risk Factors; Severity of Illness Index; Substance-Related Disorders; Taurine; Treatment Outcome	2001
Drug treatments for alcoholism. The Harvard mental health letter, 2002, Volume: 18, Issue:10 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Substance Withdrawal Syndrome; Taurine	2002
Physicians' opinions about medications to treat alcoholism. Addiction (Abingdon, England), 2003, Volume: 98, Issue:5 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Attitude of Health Personnel; Clinical Competence; Disulfiram; Health Care Surveys; Humans; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome	2003
The treatment of alcohol dependence--new horizons. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:4 Topics: Alcohol Deterrents; Alcoholics Anonymous; Alcoholism; Contraindications; Disulfiram; Humans; Naltrexone	2004
Ask the doctor. I need to quit drinking, but don't think I can do it on my own. Can I use a drug like Antabuse even though I have heart disease? Harvard heart letter : from Harvard Medical School, 2004, Volume: 15, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Contraindications; Disulfiram; Heart Diseases; Humans; Naltrexone; Taurine	2004
Acamprosate campral for alcoholism. The Medical letter on drugs and therapeutics, 2005, Jan-03, Volume: 47, Issue:1199 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Diarrhea; Disulfiram; Drug Therapy, Combination; Humans; Naltrexone; Taurine	2005
[The pharmacologic treatment of the alcohol dependence]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2004, Volume: 26 Suppl 1 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine	2004
Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry. Alcoholism, clinical and experimental research, 2005, Volume: 29, Issue:8 Topics: Academies and Institutes; Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Cooperative Behavior; Cross-Cultural Comparison; Disulfiram; Drug Approval; Drug Industry; Drugs, Investigational; Evidence-Based Medicine; Humans; Interprofessional Relations; Naltrexone; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Taurine	2005
Drug treatment for alcoholism today. The Harvard mental health letter, 2005, Volume: 22, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Disulfiram; Fructose; Humans; Naltrexone; Substance Withdrawal Syndrome; Taurine; Topiramate	2005
New alcohol abuse drugs emerging. Anti-craving meds are finally here to treat alcohol dependence, recognized as a disease of the brain. Health news (Waltham, Mass.), 2005, Volume: 11, Issue:12 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Taurine	2005
The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders. Journal of psychiatric practice, 2006, Volume: 12, Issue:2 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Attitude to Health; Disulfiram; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Compliance; Psychological Theory; Psychology; Psychotherapy; Taurine	2006
[Maintaining abstinence after alcohol detoxification]. La Revue du praticien, 2006, May-31, Volume: 56, Issue:10 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Ambulatory Care; Behavior Therapy; Clinical Protocols; Cognitive Behavioral Therapy; Disulfiram; Follow-Up Studies; Humans; Naltrexone; Patient Care Planning; Psychoanalytic Therapy; Psychotherapy, Group; Psychotropic Drugs; Social Support; Taurine; Temperance	2006
The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters. Drug and alcohol dependence, 2007, Mar-16, Volume: 87, Issue:2-3 Topics: Community Mental Health Centers; Disulfiram; Humans; Multivariate Analysis; Naltrexone; Narcotic Antagonists; National Institutes of Health (U.S.); Regression Analysis; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome; United States	2007
Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler. Drugs, 2006, Volume: 66, Issue:13 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Delayed-Action Preparations; Disulfiram; Humans; Injections, Intramuscular; Naltrexone; Narcotic Antagonists; Taurine	2006
[Drugs against alcohol abuse]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2006, Dec-14, Volume: 126, Issue:24 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Drug Evaluation; Humans; Naltrexone; Narcotic Antagonists; Taurine; Treatment Outcome	2006
Alcohol dependence and pharmacologic treatment. Introduction. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Mar-01, Volume: 64, Issue:5 Suppl 3 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Humans; Naltrexone; Taurine; United States	2007
Schizophrenia and co-occurring substance use disorder. The American journal of psychiatry, 2007, Volume: 164, Issue:3 Topics: Acamprosate; Adult; Alcohol-Related Disorders; Antipsychotic Agents; Comorbidity; Diagnosis, Dual (Psychiatry); Disulfiram; Humans; Ill-Housed Persons; Male; Naltrexone; Schizophrenia; Substance-Related Disorders; Taurine	2007
Availability of addiction medications in private health plans. Journal of substance abuse treatment, 2008, Volume: 34, Issue:2 Topics: Alcohol Deterrents; Alcoholism; Buprenorphine; Cost Sharing; Data Collection; Disulfiram; Drugs, Generic; Formularies as Topic; Health Services Accessibility; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; United States	2008
New therapies for alcohol dependence open options for office-based treatment. JAMA, 2007, Dec-05, Volume: 298, Issue:21 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Behavior Therapy; Disulfiram; Family Practice; Fructose; Humans; Naltrexone; Taurine; Topiramate	2007
Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug and alcohol dependence, 2009, Jan-01, Volume: 99, Issue:1-3 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Delayed-Action Preparations; Disulfiram; Drug Costs; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Humans; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Osteopathic Medicine; Physicians; Physicians, Family; Psychiatry; Taurine; United States	2009
[Pharmacological therapy of dependency on alcohol]. Duodecim; laaketieteellinen aikakauskirja, 2009, Volume: 125, Issue:8 Topics: Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone	2009
Treatment of alcohol dependence. The Ceylon medical journal, 2009, Volume: 54, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Fructose; Humans; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Taurine; Topiramate; Vitamins	2009
Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support. Prescrire international, 2009, Volume: 18, Issue:103 Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Alcoholics; Alcoholism; Anticonvulsants; Baclofen; Clinical Trials as Topic; Combined Modality Therapy; Disulfiram; France; Fructose; Health Status; Humans; Naltrexone; Psychotherapy; Randomized Controlled Trials as Topic; Secondary Prevention; Self-Help Groups; Social Support; Taurine; Temperance; Topiramate; Treatment Outcome	2009
Pharmacotherapies for alcoholism: the old and the new. CNS & neurological disorders drug targets, 2010, Volume: 9, Issue:1 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Induced Disorders, Nervous System; Alcoholism; Animals; Disease Models, Animal; Disulfiram; Drug Design; Humans; Naltrexone; Narcotic Antagonists; Neuropeptides; Neuropharmacology; Neurotransmitter Agents; Receptors, Neurotransmitter; Taurine	2010
Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatric services (Washington, D.C.), 2010, Volume: 61, Issue:4 Topics: Acamprosate; Administration, Oral; Adult; Age Factors; Alcohol Deterrents; Alcoholism; Ambulatory Care; Comorbidity; Delayed-Action Preparations; Disulfiram; Drug Therapy, Combination; Drug Utilization; Female; Humans; Injections, Intramuscular; Male; Mental Disorders; Middle Aged; Naltrexone; Selective Serotonin Reuptake Inhibitors; Sex Factors; Substance Abuse Treatment Centers; Taurine; United States; Veterans	2010
Comparison of healthcare utilization among patients treated with alcoholism medications. The American journal of managed care, 2010, Volume: 16, Issue:12 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Delayed-Action Preparations; Disulfiram; Female; Health Services; Health Status Indicators; Humans; Inpatients; Insurance Claim Review; Male; Middle Aged; Naltrexone; Narcotics; Propensity Score; Retrospective Studies; Taurine; United States	2010
Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addictive behaviors, 2011, Volume: 36, Issue:6 Topics: Acamprosate; Alcohol Deterrents; Buprenorphine; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Patient Education as Topic; Substance Abuse Treatment Centers; Substance-Related Disorders; Taurine; United States	2011
[Anesthetic considerations in a patient taking disulfiram and naltrexone for chronic alcoholism]. Revista espanola de anestesiologia y reanimacion, 2011, Volume: 58, Issue:2 Topics: Alcohol Deterrents; Alcoholism; Anesthesia; Disulfiram; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists	2011
A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation. Journal of studies on alcohol and drugs, 2011, Volume: 72, Issue:4 Topics: Alcohol Deterrents; Alcohol-Related Disorders; Alcoholism; Databases, Factual; Disulfiram; Drug Utilization; Ethanol; Humans; Longitudinal Studies; Naltrexone; Practice Patterns, Physicians'; Substance Abuse Treatment Centers; Time Factors	2011
Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence. The American journal of managed care, 2011, Volume: 17 Suppl 8 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Chi-Square Distribution; Databases, Factual; Disulfiram; Female; Health Care Costs; Health Services; Humans; Male; Naltrexone; Narcotic Antagonists; Propensity Score; Retrospective Studies; Statistics as Topic; Statistics, Nonparametric; Taurine; Treatment Outcome; United States	2011
Pharmacogenetics of alcoholism: a clinical neuroscience perspective. Pharmacogenomics, 2012, Volume: 13, Issue:2 Topics: Acamprosate; Alcoholism; Alleles; Disulfiram; Genetic Markers; Humans; Naltrexone; Narcotic Antagonists; Polymorphism, Single Nucleotide; Precision Medicine; Receptors, Opioid, mu; Serotonin Plasma Membrane Transport Proteins; Taurine	2012
Pharmacotherapy for adolescent alcohol use disorder. CNS drugs, 2012, Jul-01, Volume: 26, Issue:7 Topics: Acamprosate; Adolescent; Alcohol-Related Disorders; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Central Nervous System Stimulants; Comorbidity; Diagnostic and Statistical Manual of Mental Disorders; Disulfiram; Humans; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders; Taurine	2012
Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychological services, 2013, Volume: 10, Issue:4 Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcoholism; Attitude of Health Personnel; Disulfiram; Drug Utilization; Female; Formularies as Topic; Health Care Surveys; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Preference; Practice Guidelines as Topic; Practice Patterns, Physicians'; Qualitative Research; Taurine; United States; United States Department of Veterans Affairs; Veterans Health	2013
Adoption and diffusion of evidence-based addiction medications in substance abuse treatment. Health services research, 2014, Volume: 49, Issue:1 Topics: Alcohol Deterrents; Buprenorphine; Diffusion of Innovation; Disulfiram; Evidence-Based Medicine; Health Services Research; Humans; Naltrexone; Narcotic Antagonists; Practice Patterns, Physicians'; Substance Abuse Treatment Centers; Substance-Related Disorders; Surveys and Questionnaires; United States	2014
KASL clinical practice guidelines: management of alcoholic liver disease. Clinical and molecular hepatology, 2013, Volume: 19, Issue:3 Topics: Alcohol Abstinence; Alcohol Drinking; Alcohol-Related Disorders; Baclofen; Disulfiram; Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Humans; Liver Cirrhosis; Liver Diseases, Alcoholic; Naltrexone; Prevalence; Prognosis; Risk Factors; Severity of Illness Index; Surveys and Questionnaires	2013
Pharmacotherapy for Adults with Alcohol Use Disorder. American family physician, 2016, Jul-15, Volume: 94, Issue:2 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Taurine	2016
Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe. European addiction research, 2016, Volume: 22, Issue:6 Topics: Acamprosate; Alcohol Abstinence; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Europe; Humans; Marketing; Naltrexone; Narcotic Antagonists; Perception; Practice Guidelines as Topic; Societies, Medical; Surveys and Questionnaires; Taurine; Treatment Outcome	2016
Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness. Addiction science & clinical practice, 2016, 09-15, Volume: 11, Issue:1 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Female; Fructose; Humans; Male; Middle Aged; Naltrexone; Patient Compliance; Taurine; Topiramate; United States; United States Department of Veterans Affairs; Veterans; Young Adult	2016
More Treatments on Deck for Alcohol Use Disorder. JAMA, 2017, Jun-13, Volume: 317, Issue:22 Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Amines; Baclofen; Cyclohexanecarboxylic Acids; Cytidine Diphosphate Choline; Disulfiram; Drug Repositioning; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Mifepristone; Naltrexone; National Institute on Alcohol Abuse and Alcoholism (U.S.); Off-Label Use; Patient Acceptance of Health Care; Taurine; Topiramate; United States; Varenicline	2017
Use of drugs for alcohol use disorder in Norway 2004–16. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2018, 11-13, Volume: 138, Issue:18 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Disulfiram; Drug Prescriptions; Drug Utilization; Female; Humans; Male; Middle Aged; Naltrexone; Norway; Registries	2018
Prescription Drug and Alcohol Use Disorders: Alcohol Use Disorder. FP essentials, 2019, Volume: 478 Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Disulfiram; Humans; Naltrexone	2019
Dispensing of medication for alcohol use disorder; an examination of large databases in a New Zealand context. The New Zealand medical journal, 2019, 05-17, Volume: 132, Issue:1495 Topics: Alcohol Deterrents; Alcoholism; Antidepressive Agents; Depressive Disorder, Major; Disulfiram; Female; Humans; Male; Middle Aged; Naltrexone; New Zealand; Quetiapine Fumarate	2019
Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population. Journal of studies on alcohol and drugs, 2019, Volume: 80, Issue:5 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; Female; Humans; Male; Medication Adherence; Middle Aged; Naltrexone; Retrospective Studies; United States; United States Department of Veterans Affairs; United States Food and Drug Administration; Veterans	2019
Comparison of Disulfiram and Naltrexone in Cases of Alcohol Dependence Syndrome. Journal of Nepal Health Research Council, 2020, Apr-20, Volume: 18, Issue:1 Topics: Adult; Alcohol Deterrents; Alcoholism; Cross-Sectional Studies; Disulfiram; Female; Humans; Male; Middle Aged; Naltrexone; Nepal; Prospective Studies; Recurrence; Treatment Outcome	2020
Treatment of Alcohol Use Disorder. JAMA, 2021, 02-09, Volume: 325, Issue:6 Topics: Acamprosate; Alcohol Deterrents; Alcoholics Anonymous; Alcoholism; Cognitive Behavioral Therapy; Disulfiram; Humans; Naltrexone	2021